Back | Next |
home / stock / bior / bior message board
Subject | By | Source | When |
---|---|---|---|
Hodling | masterofdisaster | investorshub | 01/18/2023 12:07:46 AM |
My number 1 squeeze potential stock here | masterofdisaster | investorshub | 01/17/2023 3:59:08 PM |
CTB now 261% | masterofdisaster | investorshub | 01/16/2023 9:48:54 PM |
CTB now 224% | masterofdisaster | investorshub | 01/16/2023 4:54:41 PM |
CTB now 206.9% | masterofdisaster | investorshub | 01/15/2023 3:06:48 AM |
Loaded the dip 2 times over | harry crumb | investorshub | 01/13/2023 9:58:53 PM |
CTB 176% now.....buying the dip | masterofdisaster | investorshub | 01/13/2023 7:18:40 PM |
The order flow showed more buying then selling | masterofdisaster | investorshub | 01/13/2023 12:42:09 PM |
Volume will kick back in any day. Holding | masterofdisaster | investorshub | 01/13/2023 12:39:59 PM |
Yes sir agree 100%, most bios constantly dilute, | harry crumb | investorshub | 01/13/2023 2:36:18 AM |
I gotcha, understood. But il make wealth on | harry crumb | investorshub | 01/13/2023 2:34:32 AM |
https://fintel.io/ss/us/bior | masterofdisaster | investorshub | 01/13/2023 2:07:59 AM |
This stock has been a diluting POS for | masterofdisaster | investorshub | 01/13/2023 1:59:35 AM |
Cost to borrow | masterofdisaster | investorshub | 01/13/2023 1:42:20 AM |
Ctb? | harry crumb | investorshub | 01/13/2023 12:45:21 AM |
Looking at AH there is still selling, this | harry crumb | investorshub | 01/13/2023 12:43:38 AM |
CTB just jumped from 13% to 115% with | masterofdisaster | investorshub | 01/13/2023 12:28:22 AM |
$BIOR is about to go parabolic | masterofdisaster | investorshub | 01/13/2023 12:25:40 AM |
Is Biora Therapeutics (PROG) Stock About to Go Big? | AstronautApe_888 | investorshub | 01/12/2023 4:51:23 AM |
That pop after the halt was a sweet one | harry crumb | investorshub | 01/12/2023 1:29:47 AM |
News, Short Squeeze, Breakout and More Instantly...
Biora Therapeutics Inc. Company Name:
BIOR Stock Symbol:
NASDAQ Market:
Dosing of all patients in clinical trial of BT-600 has been successfully completed, with results anticipated in late Q2 2024 Clinical data on devi...
Dosing of all patients in clinical trial of BT-600 has been successfully completed, with results anticipated in late Q2 2024 Clinical data on device function of the NaviCap™ platform to be presented at DDW on May 19 Partnering process for the BioJet oral delivery platform...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...